Literature DB >> 20186710

Toward a comprehensive neurobiology of IGF-I.

Ignacio Torres-Aleman1.   

Abstract

Insulin-like growth factor I (IGF-I) belongs to an ancient family of hormones already present in early invertebrates. The insulin family is well characterized in mammals, although new members have been described recently. Since its characterization over 50 years ago, IGF-I has been considered a peptide mostly involved in the control of body growth and tissue remodeling. Currently, its most prominent recognized role is as a quasi-universal cytoprotectant. This role connects IGF-I with regulation of lifespan and with cancer, two areas of very active research in relation to this peptide. In the brain, IGF-I was formerly considered a neurotrophic factor involved in brain growth, as many other neurotrophic factors. Other aspects of the neurobiology of IGF-I are gradually emerging and suggest that this growth factor has a prominent role in brain function as a whole. During development IGF-I is abundantly expressed in many areas, whereas once the brain is formed its expression is restricted to a few regions and in very low quantities. However, the adult brain appears to have an external input from serum IGF-I, where this anabolic peptide is abundant. Thus, serum IGF-I has been proven to be an important modulator of brain activity, including higher functions such as cognition. Many of these functions can be ascribed to its tissue-remodeling activity as IGF-I modulates adult neurogenesis and angiogenesis. Other activities are cytoprotective; indeed, IGF-I can be considered a key neuroprotective peptide. Still others pertain to the functional characteristics of brain cells, such as cell excitability. Through modulation of membrane channels and neurotransmission, IGF-I impinges directly on neuronal plasticity, the cellular substrate of cognition. However, to fully understand the role of IGF-I in the brain, we have to sum the actions of locally produced IGF-I to those of serum IGF-I, and this is still pending. Thus, an integrated view of the role played by IGF-I in the brain is not yet possible. An operational approach to overcome this limitation would be to consider IGF-I as a signal coupling environmental influences on body metabolism with brain function. Or in a more colloquial way, we may say that IGF-I links body "fitness" with brain fitness, providing a mechanism to the roman saying "mens sana in corpore sano."

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20186710     DOI: 10.1002/dneu.20778

Source DB:  PubMed          Journal:  Dev Neurobiol        ISSN: 1932-8451            Impact factor:   3.964


  62 in total

1.  Light stimuli control neuronal migration by altering of insulin-like growth factor 1 (IGF-1) signaling.

Authors:  Ying Li; Yutaro Komuro; Jennifer K Fahrion; Taofang Hu; Nobuhiko Ohno; Kathleen B Fenner; Jessica Wooton; Emilie Raoult; Ludovic Galas; David Vaudry; Hitoshi Komuro
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-30       Impact factor: 11.205

2.  MiR-126 Regulates Growth Factor Activities and Vulnerability to Toxic Insult in Neurons.

Authors:  Woori Kim; Haneul Noh; Yenarae Lee; Jeha Jeon; Arthi Shanmugavadivu; Donna L McPhie; Kwang-Soo Kim; Bruce M Cohen; Hyemyung Seo; Kai C Sonntag
Journal:  Mol Neurobiol       Date:  2014-11-19       Impact factor: 5.590

3.  Retracted: Involvement of insulin-like growth factor-1 in chemotherapy-related cognitive impairment.

Authors:  Teresita L Briones; Julie Woods; Magdalena Wadowska
Journal:  Behav Brain Res       Date:  2014-03-12       Impact factor: 3.332

Review 4.  Role of Insulinlike Growth Factor 1 in Fetal Development and in the Early Postnatal Life of Premature Infants.

Authors:  Ann Hellström; David Ley; Ingrid Hansen-Pupp; Boubou Hallberg; Luca A Ramenghi; Chatarina Löfqvist; Lois E H Smith; Anna-Lena Hård
Journal:  Am J Perinatol       Date:  2016-09-07       Impact factor: 1.862

Review 5.  The Dynamics of Neurosteroids and Sex-Related Hormones in the Pathogenesis of Alzheimer's Disease.

Authors:  Milad Hasanpour; Alireza Nourazarian; Mohammad Hossein Geranmayeh; Masoud Nikanfar; Fatemeh Khaki-Khatibi; Reza Rahbarghazi
Journal:  Neuromolecular Med       Date:  2018-05-04       Impact factor: 3.843

6.  miR-126 contributes to Parkinson's disease by dysregulating the insulin-like growth factor/phosphoinositide 3-kinase signaling.

Authors:  Woori Kim; Yenarae Lee; Noah D McKenna; Ming Yi; Filip Simunovic; Yulei Wang; Benjamin Kong; Robert J Rooney; Hyemyung Seo; Robert M Stephens; Kai C Sonntag
Journal:  Neurobiol Aging       Date:  2014-01-24       Impact factor: 4.673

7.  Nutrition, insulin-like growth factor-1 and retinopathy of prematurity.

Authors:  Anna-Lena Hård; Lois E Smith; Ann Hellström
Journal:  Semin Fetal Neonatal Med       Date:  2013-02-18       Impact factor: 3.926

8.  Endothelin-1-induced focal cerebral ischemia in the growth hormone/IGF-1 deficient Lewis Dwarf rat.

Authors:  Han Yan; Matthew Mitschelen; Peter Toth; Nicole M Ashpole; Julie A Farley; Erik L Hodges; Junie P Warrington; Song Han; Kar-Ming Fung; Anna Csiszar; Zoltan Ungvari; William E Sonntag
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2014-08-06       Impact factor: 6.053

Review 9.  Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums.

Authors:  Steven E Arnold; Zoe Arvanitakis; Shannon L Macauley-Rambach; Aaron M Koenig; Hoau-Yan Wang; Rexford S Ahima; Suzanne Craft; Sam Gandy; Christoph Buettner; Luke E Stoeckel; David M Holtzman; David M Nathan
Journal:  Nat Rev Neurol       Date:  2018-01-29       Impact factor: 42.937

Review 10.  Beta-amyloid monomer and insulin/IGF-1 signaling in Alzheimer's disease.

Authors:  Maria Laura Giuffrida; Flora Tomasello; Filippo Caraci; Santina Chiechio; Ferdinando Nicoletti; Agata Copani
Journal:  Mol Neurobiol       Date:  2012-08-12       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.